Cyclodextrin Inclusion Complexes for Improved Drug Bioavailability and Activity: Synthetic and Analytical Aspects
Pharmaceutics · 19.09.2023 · 15 (9) · 2345
DOI: 10.3390/pharmaceutics15092345 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 19.09.2023. Verfasst von Álvaro Sarabia-Vallejo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Unidad de Química Orgánica y Farmacéutica, Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense, 28040 Ma…. Die Arbeit wurde bisher 205-mal zitiert (Crossref) und nennt 271 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia e Innovación, Spain.
Abstract (Originalsprache)
Many active pharmaceutical ingredients show low oral bioavailability due to factors such as poor solubility and physical and chemical instability. The formation of inclusion complexes with cyclodextrins, as well as cyclodextrin-based polymers, nanosponges, and nanofibers, is a valuable tool to improve the oral bioavailability of many drugs. The microencapsulation process modifies key properties of the included drugs including volatility, dissolution rate, bioavailability, and bioactivity. In this context, we present relevant examples of the stabilization of labile drugs through the encapsulation in cyclodextrins. The formation of inclusion complexes with drugs belonging to class IV in the biopharmaceutical classification system as an effective solution to increase their bioavailability is also discussed. The stabilization and improvement in nutraceuticals used as food supplements, which often have low intestinal absorption due to their poor solubility, is also considered. Cyclodextrin-based nanofibers, which are polymer-free and can be generated using environmentally friendly technologies, lead to dramatic bioavailability enhancements. The synthesis of chemically modified cyclodextrins, polymers, and nanosponges based on cyclodextrins is discussed. Analytical techniques that allow the characterization and verification of the formation of true inclusion complexes are also considered, taking into account the differences in the procedures for the formation of inclusion complexes in solution and in the solid state.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Unidad de Química Orgánica y Farmacéutica, Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense, 28040 Madrid, Spain.
- Unidad de Química Analítica, Departamento de Química en Ciencias Farmacéuticas, Facultad de Farmacia, Universidad Complutense, 28040 Madrid, Spain.
ORCID-Profile: Álvaro Sarabia-Vallejo, Ana I Olives, M Antonia Martín, J Carlos Menéndez
Förderung
- Ministerio de Ciencia e Innovación, Spain
Zitieren
APA
Sarabia-Vallejo, Á., Caja, M. D. M., Olives, A. I., Martín, M. A., & Menéndez, J. C. (2023). Cyclodextrin Inclusion Complexes for Improved Drug Bioavailability and Activity: Synthetic and Analytical Aspects. Pharmaceutics, 15(9), 2345. https://doi.org/10.3390/pharmaceutics15092345
Vancouver
Sarabia-Vallejo Á, Caja MDM, Olives AI, Martín MA, Menéndez JC. Cyclodextrin Inclusion Complexes for Improved Drug Bioavailability and Activity: Synthetic and Analytical Aspects. Pharmaceutics. 2023;15(9):2345. doi:10.3390/pharmaceutics15092345
BibTeX
@article{SarabiaVallejo2023,
author = {Sarabia-Vallejo, Álvaro and Caja, María Del Mar and Olives, Ana I and Martín, M Antonia and Menéndez, J Carlos},
title = {Cyclodextrin Inclusion Complexes for Improved Drug Bioavailability and Activity: Synthetic and Analytical Aspects},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {9},
pages = {2345},
doi = {10.3390/pharmaceutics15092345}
}
EUVIMED